571 related articles for article (PubMed ID: 28375789)
1. The Effect of Tear Supplementation with 0.15% Preservative-Free Zinc-Hyaluronate on Ocular Surface Sensations in Patients with Dry Eye.
Perényi K; Dienes L; Kornafeld A; Kovács B; Kiss HJ; Szepessy Z; Nagy ZZ; Barsi Á; Acosta MC; Gallar J; Kovács I
J Ocul Pharmacol Ther; 2017; 33(6):487-492. PubMed ID: 28375789
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Tear Supplementation on Ocular Surface Sensations during the Interblink Interval in Patients with Dry Eye.
Dienes L; Kiss HJ; Perényi K; Szepessy Z; Nagy ZZ; Barsi Á; Acosta MC; Gallar J; Kovács I
PLoS One; 2015; 10(8):e0135629. PubMed ID: 26302222
[TBL] [Abstract][Full Text] [Related]
3. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
Hwang HS; Sung YM; Lee WS; Kim EC
Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
[TBL] [Abstract][Full Text] [Related]
4. Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome.
Jee D; Park M; Lee HJ; Kim MS; Kim EC
J Cataract Refract Surg; 2015 Apr; 41(4):756-63. PubMed ID: 25487027
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops.
Jee D; Park SH; Kim MS; Kim EC
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5081-9. PubMed ID: 24994869
[TBL] [Abstract][Full Text] [Related]
6. Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness.
Hommer A; Schmidl D; Kromus M; Bata AM; Fondi K; Werkmeister RM; Baar C; Schmetterer L; Garhöfer G
Eur J Ophthalmol; 2018 Jul; 28(4):385-392. PubMed ID: 29592773
[TBL] [Abstract][Full Text] [Related]
7. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
Kinoshita S; Oshiden K; Awamura S; Suzuki H; Nakamichi N; Yokoi N;
Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326
[TBL] [Abstract][Full Text] [Related]
8. A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye.
Park Y; Song JS; Choi CY; Yoon KC; Lee HK; Kim HS
J Ocul Pharmacol Ther; 2017 Mar; 33(2):66-72. PubMed ID: 27929721
[TBL] [Abstract][Full Text] [Related]
9. Effects of osmoprotection on symptoms, ocular surface damage, and tear film modifications caused by glaucoma therapy.
Monaco G; Cacioppo V; Consonni D; Troiano P
Eur J Ophthalmol; 2011; 21(3):243-50. PubMed ID: 20872359
[TBL] [Abstract][Full Text] [Related]
10. Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study.
Prabhasawat P; Tesavibul N; Kasetsuwan N
Br J Ophthalmol; 2007 Jan; 91(1):47-50. PubMed ID: 16973668
[TBL] [Abstract][Full Text] [Related]
11. Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery.
Mencucci R; Boccalini C; Caputo R; Favuzza E
J Cataract Refract Surg; 2015 Aug; 41(8):1699-704. PubMed ID: 26432128
[TBL] [Abstract][Full Text] [Related]
12. Isotonic Glycerol and Sodium Hyaluronate Containing Artificial Tear Decreases Conjunctivochalasis after One and Three Months: A Self-Controlled, Unmasked Study.
Kiss HJ; Németh J
PLoS One; 2015; 10(7):e0132656. PubMed ID: 26172053
[TBL] [Abstract][Full Text] [Related]
13. The effect of sodium hyaluronate on tear film stability in patients with dry eye syndrome after cataract surgery.
Chen N; Zhang JS; Zhang TX; Fan BL; Ning Y
Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):1011-1017. PubMed ID: 36378338
[TBL] [Abstract][Full Text] [Related]
14. Sodium hyaluronate eyedrops enhance tear film stability.
Hamano T; Horimoto K; Lee M; Komemushi S
Jpn J Ophthalmol; 1996; 40(1):62-5. PubMed ID: 8739501
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease.
Lee HS; Ji YS; Yoon KC
Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018
[TBL] [Abstract][Full Text] [Related]
16. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial.
Park DH; Chung JK; Seo DR; Lee SJ
Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791
[TBL] [Abstract][Full Text] [Related]
17. OCT assessment of tear meniscus after punctal occlusion in dry eye disease.
Ibrahim OM; Dogru M; Kojima T; Matsumoto Y; Wakamatsu TH; Tsubota K; Fujishima H
Optom Vis Sci; 2012 May; 89(5):E770-6. PubMed ID: 22466101
[TBL] [Abstract][Full Text] [Related]
18. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
Toker E; Asfuroğlu E
Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of rb-bFGF Eye Drops for Post-Cataract Surgery Dry Eye and Observation of Changes in Tear Secretion and Corneal Damage in Patients.
Zhao X; Jia Q; Fu J
Altern Ther Health Med; 2023 Nov; 29(8):489-495. PubMed ID: 37652420
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Sodium Hyaluronate/chondroitin Sulfate Preservative-free Ophthalmic Solution in the Treatment of Dry Eye: A Clinical Trial.
Belalcázar-Rey S; Sánchez Huerta V; Ochoa-Tabares JC; Altamirano Vallejo S; Soto-Gómez A; Suárez-Velasco R; García-Félix F; Baiza-Durán L; Olvera-Montaño O; Muñoz-Villegas P
Curr Eye Res; 2021 Jul; 46(7):919-929. PubMed ID: 33289602
[No Abstract] [Full Text] [Related]
[Next] [New Search]
